Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-b]pyridine anticancer compound

Tumor progression may be driven by a small subpopulation of cancer stem cells (CSCs characterized by CD44(+)/CD24(−) phenotype). We investigated the influence of a newly developed thienopyridine anticancer compound (3-amino-5-oxo-N-naphthyl-5,6,7, 8-tetrahydrothieno[2,3-b]quinoline-2-carboxamide, 1)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Des Devel Ther
Main Authors: Mastelić, Angela, Čikeš Čulić, Vedrana, Režić Mužinić, Nikolina, Vuica-Ross, Milena, Barker, David, Leung, Euphemia Y, Reynisson, Jóhannes, Markotić, Anita
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5359006/
https://ncbi.nlm.nih.gov/pubmed/28352152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S121122
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados